RB1 AND TP53 LOSS PROMOTES LINEAGE PLASTICITY IN PROSTATE CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2017年 / 7卷 / 03期
关键词：
ANTIANDROGEN RESISTANCE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [1] SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 and RB1 deficient prostate cancer
    Mu, Ping
    Zhang, Zeda
    Benelli, Matteo
    Karthaus, Wouter
    Hoover, Elizebeth
    Chen, Chi-Chao
    Wongvipat, John
    Ku, Sheng-Yu
    Gao, Dong
    Cao, Zhen
    Shah, Neel
    Adams, Elizabeth
    Abida, Wassim
    Watson, Philip
    Prandi, Davide
    Huang, Chun-Hao
    de Stanchina, Elisa
    Lowe, Scott
    Ellis, Leigh
    Beltran, Himisha
    Rubin, Mark
    Goodrich, David
    Demichelis, Francesca
    Sawyers, Charles L.
    CANCER RESEARCH, 2017, 77
  • [2] Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
    Nyquist, Michael D.
    Corella, Alexandra
    Coleman, Ilsa
    De Sarkar, Navonil
    Kaipainen, Arja
    Ha, Gavin
    Gulati, Roman
    Ang, Lisa
    Chatterjee, Payel
    Lucas, Jared
    Pritchard, Colin
    Risbridger, Gail
    Isaacs, John
    Montgomery, Bruce
    Morrissey, Colm
    Corey, Eva
    Nelson, Peter S.
    CELL REPORTS, 2020, 31 (08):
  • [3] Reversal of lineage plasticity in RB1/TP53-deleted prostate cancer through FGFR and Janus kinase inhibition
    Chan, Joseph M.
    Karthaus, Wouter R.
    Setty, Manu
    Love, Jillian R.
    Zaidi, Samir
    Zhao, Jimmy
    Choo, Zi-ning
    Persad, Sitara
    LaClair, Justin
    Lawrence, Kayla E.
    Chaudhary, Ojasvi
    Masilionis, Ignas
    Mazutis, Linas
    Chaligne, Ronan
    Pe'er, Dana
    Sawyers, Charles
    CANCER RESEARCH, 2022, 82 (12)
  • [4] TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Mu, Ping
    Cao, Zhen
    Hoover, Elizabeth
    Wongvipat, John
    Huang, Chun-Hao
    Karthaus, Wouter
    Abida, Wassim
    De Stanchina, Elise
    Sawyers, Charles
    CANCER RESEARCH, 2015, 75
  • [5] Ionizing Radiation Combined with PARP1 Inhibitor Reduces Radioresistance in Prostate Cancer with RB1/TP53 Loss
    Fan, Yao
    Fan, Hui
    Quan, Zhen
    Wu, XiaoHou
    CANCER INVESTIGATION, 2021, 39 (05) : 423 - 434
  • [6] Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.
    Hammer, Liat
    Rebernick, Ryan
    McFarlane, Matthew
    Westbrook, Thomas
    Hazime, Munna
    Hammoud, Tanya
    Chiu, Pin-en
    Xavier, Owens
    Wu, Yi-Mi
    Robinson, Dan R.
    Spratt, Daniel Eidelberg
    Alva, Ajjai Shivaram
    Jackson, William C.
    Reichert, Zachery R.
    Alumkal, Joshi J.
    Chinnaiyan, Arul
    Cieslik, Marcin
    Dess, Robert Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
    Mu, Ping
    Zhang, Zeda
    Benelli, Matteo
    Karthaus, Wouter R.
    Hoover, Elizabeth
    Chen, Chi-Chao
    Wongvipat, John
    Ku, Sheng-Yu
    Gao, Dong
    Cao, Zhen
    Shah, Neel
    Adams, Elizabeth J.
    Abida, Wassim
    Watson, Philip A.
    Prandi, Davide
    Huang, Chun-Hao
    de Stanchina, Elisa
    Lowe, Scott W.
    Ellis, Leigh
    Beltran, Himisha
    Rubin, Mark A.
    Goodrich, David W.
    Demichelis, Francesca
    Sawyers, Charles L.
    SCIENCE, 2017, 355 (6320) : 84 - 88
  • [8] Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
    Humid, Anis A.
    Gray, Kathryn P.
    Shaw, Grace
    MacConaill, Laura E.
    Evan, Carolyn
    Bernard, Brandon
    Loda, Massimo
    Corcoran, Niall M.
    Van Allen, Eliezer M.
    Choudhury, Atish D.
    Sweeney, Christopher J.
    EUROPEAN UROLOGY, 2019, 76 (01) : 89 - 97
  • [9] Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance
    Ma, Min
    Zhu, Yazhi
    Xiao, Changkai
    Li, Ruidong
    Cao, Xingyu
    Kang, Ran
    Wang, Xiaolan
    Li, Ermao
    TUMORI JOURNAL, 2024, 110 (04): : 252 - 263
  • [10] Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53
    Ueki, Hideto
    Jimbo, Naoe
    Terakawa, Tomoaki
    Hara, Takuto
    Tobe, Taisuke
    Hirata, Junichiro
    Wakita, Naoto
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Bando, Yukari
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    PROSTATE, 2024, 84 (16): : 1506 - 1514
12345